Organization
Shanghai East Hospital
21 clinical trials
2 abstracts
Abstract
Efficacy and safety of LM-108, an anti-CCR8 monoclonal antibody, in combination with an anti-PD-1 antibody in patients with gastric cancer: Results from phase 1/2 studies.Org: Peking University Cancer Hospital and Institute, Beijing, China, The First Affiliated Hospital of Henan University of Science and Technology, Shanghai East Hospital, Zhongnan Hospital of Wuhan University, The First Affiliated Hospital of Xinxiang Medical University,
Clinical trial
A Single Arm, Open Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of B4T2-001 CAR-T in Patients With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2025-03-01
Abstract
Nivolumab (NIVO) plus ipilimumab (IPI) vs chemotherapy (chemo) as first-line (1L) treatment for microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): Expanded efficacy analysis from CheckMate 8HW.Org: Bristol Myers Squibb, Cancer Research SA, Fondazione Policlinico Universitario A. Gemelli IRCCS, Institut Paoli-Calmettes, Marseille, France, Instituto Catalán de Oncología,
Clinical trial
CXCL Chemokine and TNF Superfamily Co-stimulatory Molecule-modified Mesenchymal Stem Cells for the Treatment of Advanced Colorectal CancerStatus: Recruiting, Estimated PCD: 2026-12-01
Clinical trial
Multi-intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells for Treatment in Heart Failure Patients With Reduced Ejection Fraction: A Randomized, Double Blind, Placebo-Controlled, Prospective Clinical StudyStatus: Completed, Estimated PCD: 2023-01-17
Clinical trial
A FIH, Single Arm, Open Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of Autologous CAR T Cells Targeting BT-001 in Patients With Advanced Solid TumorsStatus: Active (not recruiting), Estimated PCD: 2024-12-31
Clinical trial
Safety and Efficacy of Tirofiban in Acute Ischemic Stroke Patients Treated With Mechanical Thrombectomy-A Prospective, Randomized, Controlled, Open-Label, Assessor-Blind, Multicenter Clinical StudyStatus: Completed, Estimated PCD: 2023-07-08
Clinical trial
Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Long COVID-19: a Randomized, Double-blind, Parallel-controlled StudyStatus: Withdrawn, Estimated PCD: 2023-12-01
Clinical trial
Efficacy and Safety of Disitamab Vedotin Combined With PD-1 in Posterior Line Therapy of Advanced HER2-low Expressing Gastric CancerStatus: Recruiting, Estimated PCD: 2025-08-01
Clinical trial
Circulating Tumor DNA Guided Adjuvant Chemotherapy for Biliary Tract Carcinoma: A Prospective Clinical TrialStatus: Not yet recruiting, Estimated PCD: 2025-11-15
Clinical trial
Effect of Human Umbilical Cord-derived Mesenchymal Stem Cells on Non-cardiac Surgery-induced Lung Injury in Patients With Ischemic Heart DiseaseStatus: Recruiting, Estimated PCD: 2023-12-01
Clinical trial
Autologous Lung Stem Cell Transplantation in Patients With Interstitial Lung DiseasesStatus: Completed, Estimated PCD: 2020-08-31
Clinical trial
Clinical Efficacy and Safety of Autologous Lung Stem Cell Transplantation in Patients With Idiopathic Pulmonary FibrosisStatus: Completed, Estimated PCD: 2020-08-31
Clinical trial
A Phase 1, Open-Label Study Evaluating the Safety, Tolerability and Efficacy of LCAR-C18S, an CAR-T Cell Therapy Targeting Claudin18.2 in Patients With Advanced Solid TumorsStatus: Terminated, Estimated PCD: 2023-07-17
Clinical trial
An Exploratory Clinical Study of JV001 in the Treatment of Patients With Heart Failure Due to Dilated Cardiomyopathy (Telomere Recapping to Restore Mitochondrial Biogenesis Study for Dilated Cardiomyopathy)Status: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
Effect of Prolonged Use of Dronedarone on Recurrence in Patients With Non-paroxysmal Atrial Fibrillation After Radiofrequency AblationStatus: Recruiting, Estimated PCD: 2025-04-01
Clinical trial
An Open-label, Single-arm, Single-dose Escalation and Multiple-dose Expansion Clinical Study of Cell Therapy to Evaluate the Tolerance, the Pharmacokinetic Characteristics, the Safety, and the Efficacy of ScTIL210 in the Treatment of Malignant Solid TumorsStatus: Recruiting, Estimated PCD: 2023-12-01
Clinical trial
Clinical Study of Stereotactic Transplantation of Human Amniotic Epithelial Stem Cells (hAESCs) in the Treatment of Parkinson's Disease (PD)Status: Completed, Estimated PCD: 2023-02-08
Clinical trial
An Investigator-initiated Trial to Evaluate the Efficacy and Safety of JAK Inhibitor Cream for the Treatment of EGFR-inhibitor-induced Skin RashStatus: Active (not recruiting), Estimated PCD: 2023-03-31
Clinical trial
Precise Transplantation of Human Amniotic Epithelial Stem Cells Into Lateral Ventricle for Parkinson's DiseaseStatus: Recruiting, Estimated PCD: 2025-02-01
Clinical trial
A Single-arm, Open-label Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Refractory Moderate to Severe Crohn's DiseaseStatus: Recruiting, Estimated PCD: 2024-08-31
Clinical trial
Efficacy of Vonoprazan-containing Triple Therapy Versus Empiric Bismuth Quadruple Therapy for First-line Helicobacter Pylori Treatment: a Randomized Clinical TrialStatus: Not yet recruiting, Estimated PCD: 2025-02-06
Clinical trial
Effect of Human Umbilical Cord Mesenchymal Stem Cells(MSCs) Transplantation for on Prognosis of Acute Cerebral Infarction PatientsStatus: Recruiting, Estimated PCD: 2024-12-30